Plasmapheresis treatment in patients with severe atopic keratoconjunctivitis.

A 19-year-old woman with hyperimmunoglobulinemia E (the hyper-IgE syndrome [HIE]) and a 62-year-old man with atopic dermatitis experienced dramatic improvement in their chronic ocular symptoms and signs of atopic keratoconjunctivitis after plasmapheresis was instituted. Both patients had previously received topical and oral corticosteroids as well as topical cromolyn sodium without significant beneficial effect. The authors recommend a trial of plasmapheresis in selected patients with recalcitrant and debilitating atopic keratoconjunctivitis when standard therapy proves unsuccessful.
AuthorsM I Aswad, J Tauber, J Baum
JournalOphthalmology (Ophthalmology) Vol. 95 Issue 4 Pg. 444-7 (Apr 1988) ISSN: 0161-6420 [Print] UNITED STATES
PMID3174011 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin G
  • Adult
  • Dermatitis, Atopic (complications, pathology, therapy)
  • Female
  • Humans
  • Hypergammaglobulinemia (complications, therapy)
  • Hypersensitivity (complications, therapy)
  • Immunoglobulin G
  • Keratitis (etiology, pathology)
  • Keratoconjunctivitis (complications, etiology, therapy)
  • Male
  • Middle Aged
  • Plasmapheresis
  • Staphylococcal Infections (complications)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: